BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Cervical cancer AND SET, I2PP2A, 6418, ENSG00000119335, TAF-IBETA, PHAPII, IGAAD, 2PP2A AND Clinical Outcome
20 results:

  • 1. APOBEC3C is a novel target for the immune treatment of lower-grade gliomas.
    Zhao S; Li Y; Xu J; Shen L
    Neurol Res; 2024 Mar; 46(3):227-242. PubMed ID: 38007705
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Diffusion basis spectrum imaging predicts long-term clinical outcomes following surgery in cervical spondylotic myelopathy.
    Zhang JK; Jayasekera D; Javeed S; Greenberg JK; Blum J; Dibble CF; Sun P; Song SK; Ray WZ
    Spine J; 2023 Apr; 23(4):504-512. PubMed ID: 36509379
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Radiomics-based prediction of two-year clinical outcome in locally advanced cervical cancer patients undergoing neoadjuvant chemoradiotherapy.
    Autorino R; Gui B; Panza G; Boldrini L; Cusumano D; Russo L; Nardangeli A; Persiani S; Campitelli M; Ferrandina G; Macchia G; Valentini V; Gambacorta MA; Manfredi R
    Radiol Med; 2022 May; 127(5):498-506. PubMed ID: 35325372
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Impact of PET scanner non-linearity on the estimation of hypoxic fraction in cervical cancer patients.
    Gottwald J; Han K; Milosevic M; Yeung I; Jaffray DA
    Phys Med; 2022 Jan; 93():1-7. PubMed ID: 34894495
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Bioinformatic identification of genomic instability-associated lncRNAs signatures for improving the clinical outcome of cervical cancer by a prognostic model.
    Zhang J; Ding N; He Y; Tao C; Liang Z; Xin W; Zhang Q; Wang F
    Sci Rep; 2021 Oct; 11(1):20929. PubMed ID: 34686717
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Downregulation of CCL22 and mutated NOTCH1 in tongue and mouth floor squamous cell carcinoma results in decreased Th2 cell recruitment and expression, predicting poor clinical outcome.
    Li X; Liu Z; Zhou W; Liu X; Cao W
    BMC Cancer; 2021 Aug; 21(1):922. PubMed ID: 34391381
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. HPV transcript expression affects cervical cancer response to chemoradiation.
    Ruiz FJ; Inkman M; Rashmi R; Muhammad N; Gabriel N; Miller CA; McLellan MD; Goldstein M; Markovina S; Grigsby PW; Zhang J; Schwarz JK
    JCI Insight; 2021 Aug; 6(16):. PubMed ID: 34255749
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Identification and Validation of Reference Genes for RT-qPCR Studies of Hypoxia in Squamous cervical cancer Patients.
    Fjeldbo CS; Aarnes EK; Malinen E; Kristensen GB; Lyng H
    PLoS One; 2016; 11(5):e0156259. PubMed ID: 27244197
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Distinct lymphocyte antigens 6 (Ly6) family members Ly6D, Ly6E, Ly6K and Ly6H drive tumorigenesis and clinical outcome.
    Luo L; McGarvey P; Madhavan S; Kumar R; Gusev Y; Upadhyay G
    Oncotarget; 2016 Mar; 7(10):11165-93. PubMed ID: 26862846
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Immunotherapy in new pre-clinical models of HPV-associated oral cancers.
    Paolini F; Massa S; Manni I; Franconi R; Venuti A
    Hum Vaccin Immunother; 2013 Mar; 9(3):534-43. PubMed ID: 23296123
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Risk assessment tool for distant recurrence after platinum-based concurrent chemoradiation in patients with locally advanced cervical cancer: a Korean gynecologic oncology group study.
    Kang S; Nam BH; Park JY; Seo SS; Ryu SY; Kim JW; Kim SC; Park SY; Nam JH
    J Clin Oncol; 2012 Jul; 30(19):2369-74. PubMed ID: 22614984
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Reporting and validation of gynaecological Groupe Euopeen de Curietherapie European Society for Therapeutic Radiology and Oncology (ESTRO) brachytherapy recommendations for MR image-based dose volume parameters and clinical outcome with high dose-rate brachytherapy in cervical cancers: a single-institution initial experience.
    Mahantshetty U; Swamidas J; Khanna N; Engineer R; Merchant NH; Deshpande DD; Shrivastava S
    Int J Gynecol Cancer; 2011 Aug; 21(6):1110-6. PubMed ID: 21633296
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Intensity-modulated radiotherapy in patients with cervical cancer. An intra-individual comparison of prone and supine positioning.
    Stromberger C; Kom Y; Kawgan-Kagan M; Mensing T; Jahn U; Schneider A; Budach V; Köhler C; Marnitz S
    Radiat Oncol; 2010 Jul; 5():63. PubMed ID: 20598136
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Proteomic profiling of mammary carcinomas identifies C7orf24, a gamma-glutamyl cyclotransferase, as a potential cancer biomarker.
    Gromov P; Gromova I; Friis E; Timmermans-Wielenga V; Rank F; Simon R; Sauter G; Moreira JM
    J Proteome Res; 2010 Aug; 9(8):3941-53. PubMed ID: 20527979
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Gene expression changes in cervical squamous cell carcinoma after initiation of chemoradiation and correlation with clinical outcome.
    Klopp AH; Jhingran A; Ramdas L; Story MD; Broadus RR; Lu KH; Eifel PJ; Buchholz TA
    Int J Radiat Oncol Biol Phys; 2008 May; 71(1):226-36. PubMed ID: 18406887
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Assessing the difference between planned and delivered intensity-modulated radiotherapy dose distributions based on radiobiological measures.
    Mavroidis P; Ferreira BC; Papanikotaou N; Svensson R; Kappas C; Lind BK; Brahme A
    Clin Oncol (R Coll Radiol); 2006 Sep; 18(7):529-38. PubMed ID: 16969983
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. HIV infection and invasive cervical cancers, treatment with radiation therapy: toxicity and outcome.
    Shrivastava SK; Engineer R; Rajadhyaksha S; Dinshaw KA
    Radiother Oncol; 2005 Jan; 74(1):31-5. PubMed ID: 15683666
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Reproducibility in double scanning of cervical smears with the PAPNET system.
    Doornewaard H; van der Schouw YT; van der Graaf Y
    Acta Cytol; 2000; 44(4):604-10. PubMed ID: 10934954
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. The increment of micronucleus frequency in cervical carcinoma during irradiation in vivo and its prognostic value for tumour radiocurability.
    Widel M; Jedruś S; Owczarek S; Konopacka M; Lubecka B; Kołosza Z
    Br J Cancer; 1999 Jul; 80(10):1599-607. PubMed ID: 10408406
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Detection and typing of human papillomavirus in cervical carcinomas in Russian women: a prognostic study.
    van Muyden RC; ter Harmsel BW; Smedts FM; Hermans J; Kuijpers JC; Raikhlin NT; Petrov S; Lebedev A; Ramaekers FC; Trimbos JB; Kleter B; Quint WG
    Cancer; 1999 May; 85(9):2011-6. PubMed ID: 10223243
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.